Additional functions of PHD3, for example, related to the control of the hypoxic response, are likely to further contribute to the selection of tumour cells with PHD3 loss, as suggested by the fact that epigenetic PHD3 silencing was also observed in low-grade gliomas, where EGFR signalling is not thought to play a major role. This evidence concerns the gene EGFR and central nervous system cancer.